From GlobeNewswire: 2024-06-14 02:00:00

The Global Intensity Modulated Radiation Therapy Market is expected to grow from USD 2.4 billion in 2023 to USD 4.06 billion by 2033, with a CAGR of 5.40%. IMRT uses advanced radiation beams to destroy cancer cells, mimicking their shape for precise treatment. Factors driving market expansion include the growth in cancer prevalence, need for targeted treatments, and aging population.

Proton radiation dominates the IMRT market, with benefits that are researched for specific clinical settings. The brain cancer application segment is influential in the IMRT market, driven by patient interest in non-surgical cancer treatment. Hospitals are a key end-user segment, with skilled healthcare personnel and well-developed facilities contributing to market growth.

North America leads the IMRT market, driven by the increasing number of cancer cases and advanced healthcare infrastructure availability. The Asia-Pacific region is expected to grow rapidly due to factors like a rise in the number of patients, healthcare system cost increase, and awareness about radiation therapy benefits. Major vendors in the market include Mevion Medical Systems, Siemens Healthcare GmbH, Hitachi, Ltd., and others.

A recent development includes RaySearch Laboratories AB’s strategic partnership with B dot Medical Inc. to advance proton therapy. The global IMRT market is segmented by radiation type, application (prostate, lung, breast, brain, gynecological cancers), and end-user (hospital, standalone radiation therapy center) across regions like North America, Europe, Asia-Pacific, and more.iationException Introducing motion to electrons:relative motion.syntax Enabling high performance.



Read more at GlobeNewswire: Global Intensity Modulated Radiation Therapy Market Size To